-
TaqI Restriction Endonuclease: Practical Digestion Guide
2026-08-28
TaqI Restriction Endonuclease (SKU K3053) provides rapid sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA within a stated 5–15 minute digestion window. It is intended for research workflows such as DNA mapping, cloning, and gel analysis, not for diagnostic, clinical, or medical use.
-
Direct Mouse Genotyping Kit Plus for Lineage Studies
2026-08-27
The Direct Mouse Genotyping Kit Plus connects rapid tissue-lysate PCR with more rigorous interpretation of lineage-tracing and colony data. Learn how its purification-free workflow, high-fidelity chemistry, and dye-containing master mix can support transgene detection, knockout validation, and assay quality control.
-
HyperPFU™ high-fidelity DNA polymerase Guide
2026-08-27
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates where proofreading and processivity are important. It produces blunt-ended PCR products, so it should not be selected directly for workflows requiring 3′-A overhangs or pre-formed sticky ends.
-
Deuterated Tetrazole CYP51 Inhibitor V23
2026-08-26
A 2025 European Journal of Medicinal Chemistry study describes V23, a deuterated tetrazole CYP51 inhibitor derived from an effort to improve the selectivity and metabolic stability of an earlier lead. V23 combined broad antifungal activity, activity against resistant organisms, antibiofilm and antimorphogenic effects, low cellular toxicity, and significant in vivo efficacy, supporting further development for invasive fungal infections.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-26
The reference study identifies CD44 as a functional dependency in IDH-mutant leukemia, linking cell-surface signaling to pentose phosphate pathway activity, NADPH generation, and sustained R-2-hydroxyglutarate production. Its findings support a combination strategy in which mutant IDH inhibition is paired with CD44 blockade to address metabolic adaptation and potential resistance.
-
E-64d Workflows for Protease Mechanism Studies
2026-08-25
E-64d combines cell permeability with irreversible cysteine protease inhibition, making it useful for dissecting intracellular calpain and cathepsin contributions to platelet activation, apoptosis, and neurobiology. This guide translates that chemical profile into practical workflows and shows how E-64d can serve as a hypothesis-testing perturbation in gibberellin–autophagy studies.
-
NIR-Triggered Cobalt Single-Atom Enzyme Phototherapy
2026-08-25
The reference study develops cobalt single-atom enzymes anchored on hollow N-doped carbon spheres as a near-infrared-triggered platform for integrated photodynamic, photocatalytic, and photothermal therapy. Its central contribution is a mechanistic design in which photogenerated electrons and mild photothermal heating reinforce reactive oxygen species production while supporting apoptosis, ferroptosis, and preservation of local tissue function.
-
From Barrier Biology to Faster Genotyping
2026-08-24
Mechanistic studies of intestinal barrier repair show why genotype, model identity, and phenotype must be connected in one translational workflow. This thought-leadership guide explains how the Genotyping Kit for target alleles of insects, tissues, fishes and cells can streamline PCR-based model validation while clarifying its evidence boundaries.
-
Kupffer Cell Plasticity in Liver Metastasis
2026-08-24
The reference study shows that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing and single-cell approaches reveal why blocking monocyte-derived macrophages alone may produce limited effects and identify combined control of recruitment and proliferation as a more rational research direction.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-23
Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be cryopreserved, expanded, and differentiated into intestinal epithelial cells with enterocyte-associated CYP and transporter activities, creating a more human-relevant platform for oral drug pharmacokinetic studies.
-
DdmDE Plasmid Clearance by Bidirectional DNA Extrusion
2026-08-22
Yang et al. identify a dynamic DdmDE mechanism in which DNA-guided DdmE recognizes destabilized plasmid DNA, recruits DdmD, and drives bidirectional ssDNA extrusion followed by site-specific cleavage. The study clarifies how a pAgo-associated helicase-nuclease module converts target recognition into physical plasmid destruction and provides a framework for analyzing cooperative bacterial defense systems.
-
MK-571: Mapping Dual-Pathway Assay Signals
2026-08-22
MK-571 (L-660,711) is a powerful probe for separating cysLT1 receptor pharmacology from ABCC1/MRP1 transport effects. This guide develops an orthogonal assay framework for interpreting inflammation, macrophage protection, and drug-resistance phenotypes.
-
Microfluidic Modeling of Gut Neuro-Epithelial Connections
2026-08-21
de Hoyos-Vega and colleagues developed a two-compartment microfluidic device that organizes human intestinal epithelial cells and mouse enteric neurons in a controllable co-culture system. The platform preserved epithelial characteristics, enabled neuronal projections through microgrooves, and revealed that adjacent epithelium increased projection density and directionality.
-
AZD6482: PI3Kβ Inhibitor Workflow Guide
2026-08-20
AZD6482 combines strong biochemical potency against PI3Kβ with a practical window for platelet, metabolic, and pathway-dissection studies. This workflow guide also shows how to use it as a carefully controlled perturbation in RNA-foci experiments inspired by recent Myotonic Dystrophy type 1 research.
-
Oteseconazole (VT-1161) Candida Workflows
2026-08-20
Oteseconazole (VT-1161) combines selective fungal CYP51 inhibition with strong in vitro activity across clinically important Candida species, including fluconazole-resistant isolates. This practical guide shows how to convert the compound into reproducible susceptibility, resistance, selectivity, and follow-up mechanism workflows.